Bruker • Microbiology and Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Bruker • Microbiology and Diagnostics's estimated annual revenue is currently $2.4B per year.
- Bruker • Microbiology and Diagnostics's estimated revenue per employee is $17,878,788
- Bruker • Microbiology and Diagnostics's current valuation is $10.7B. (January 2022)
Employee Data
- Bruker • Microbiology and Diagnostics has 132 Employees.
- Bruker • Microbiology and Diagnostics grew their employee count by 23% last year.
Bruker • Microbiology and Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | AVP Finance | Reveal Email/Phone |
2 | VP Finance | Reveal Email/Phone |
3 | Head Facility Management, Project Manager | Reveal Email/Phone |
4 | VP Operations | Reveal Email/Phone |
5 | Head AXS Service Academy | Reveal Email/Phone |
6 | Head Machine Shop | Reveal Email/Phone |
7 | Head Sales & Service Support DACH-NL | Reveal Email/Phone |
8 | Head Controlling Bruker AXS Division | Reveal Email/Phone |
9 | Head the XRD application team | Reveal Email/Phone |
10 | Head Analytics team | Reveal Email/Phone |
Bruker • Microbiology and Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Bruker • Microbiology and Diagnostics?
N/A
Total Funding
132
Number of Employees
$2.4B
Revenue (est)
23%
Employee Growth %
$10.7B
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.5M | 132 | 65% | N/A |
#2 | $19.8M | 132 | 6% | N/A |
#3 | N/A | 132 | 5% | N/A |
#4 | $23.8M | 132 | 9% | N/A |
#5 | $30M | 132 | N/A | N/A |